Literature DB >> 12357368

Angio-immunoblastic T cell lymphoma (AILD-TL) rich in large B cells and associated with Epstein-Barr virus infection. A different subtype of AILD-TL?

C Lome-Maldonado1, D Canioni, O Hermine, E Delabesse, D Damotte, E Raffoux, P Gaulard, E Macintyre, N Brousse.   

Abstract

We studied eight patients with characteristic features of angio-immunoblastic T cell lymphoma (AILD-TL) associated with more than 25% of large B cells. Polymerase chain reaction (PCR) analysis showed a clonal rearrangement of the T cell receptor (TCR)-gamma chain gene in all cases. One additional case showed a clonal rearrangement of the TCR-beta chain gene by Southern blot hybridization. PCR analysis showed a clonal immunoglobulin rearrangement in three cases presenting with more than 50% of large B cells whereas the other cases had a germline configuration. In 6/8 cases, double-labeling immunohistochemistry and in situ hybridization demonstrated that Epstein-Barr virus (EBV) was mostly present in the large B cells but also detected in some T cells. We further evaluated the frequency of AILD-TL with more than 25% of large B cells in the 106 cases collected by the French GELA group and found an incidence of 18%. The outcome of these patients did not differ significantly from those with less than 25% of B cells. With this approach we confirm the heterogeneity of AILD-TL features and the possible association with a substantial numbers of CD20(+), EBV(+) large B cells. We propose to denominate these cases as 'AILD-TL rich in large B cells' and to consider them as a different entity which can be misdiagnosed as a reactive process or as T cell rich B cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12357368     DOI: 10.1038/sj.leu.2402642

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  9 in total

Review 1.  Follicular helper T cells: implications in neoplastic hematopathology.

Authors:  Philippe Gaulard; Laurence de Leval
Journal:  Semin Diagn Pathol       Date:  2011-08       Impact factor: 3.464

2.  Angioimmunoblastic T-cell lymphoma partially obscured by an Epstein-Barr virus-negative clonal plasma cell proliferation.

Authors:  Alison R Huppmann; Michele R Roullet; Mark Raffeld; Elaine S Jaffe
Journal:  J Clin Oncol       Date:  2012-12-03       Impact factor: 44.544

3.  Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA.

Authors:  Marie-Hélène Delfau-Larue; Laurence de Leval; Bertrand Joly; Anne Plonquet; Dominique Challine; Marie Parrens; Alain Delmer; Gilles Salles; Franck Morschhauser; Richard Delarue; Pauline Brice; Reda Bouabdallah; Olivier Casasnovas; Hervé Tilly; Philippe Gaulard; Corinne Haioun
Journal:  Haematologica       Date:  2012-02-27       Impact factor: 9.941

4.  The frequency of B- and T-cell gene rearrangements and epstein-barr virus in T-cell lymphomas: a comparison between angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified with and without associated B-cell proliferations.

Authors:  Brenton T Tan; Roger A Warnke; Daniel A Arber
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

Review 5.  Molecular genetics of peripheral T-cell lymphomas.

Authors:  Pier Paolo Piccaluga; Valentina Tabanelli; Stefano A Pileri
Journal:  Int J Hematol       Date:  2014-01-31       Impact factor: 2.490

6.  Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.

Authors:  Nathalie Mourad; Nicolas Mounier; Josette Brière; Emmanuel Raffoux; Alain Delmer; Alfred Feller; Chris J L M Meijer; Jean-François Emile; Réda Bouabdallah; André Bosly; Jacques Diebold; Corinne Haioun; Bertrand Coiffier; Christian Gisselbrecht; Philippe Gaulard
Journal:  Blood       Date:  2008-02-21       Impact factor: 22.113

7.  Diagnostic impact of molecular lineage analysis on paraffin-embedded tissue in hematolymphoid neoplasia reclassified by current WHO criteria.

Authors:  Leonard Hwan Cheong Tan; Lily-Lily Chiu; Evelyn Siew Chuan Koay
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

8.  The frequency of immunoglobulin heavy chain gene and T-cell receptor gamma-chain gene rearrangements and Epstein-Barr virus in ALK+ and ALK- anaplastic large cell lymphoma and other peripheral T-cell lymphomas.

Authors:  Brent T Tan; Katie Seo; Roger A Warnke; Daniel A Arber
Journal:  J Mol Diagn       Date:  2008-10-02       Impact factor: 5.568

9.  Angioimmunoblastic T-Cell Lymphoma Presenting with an Acute Serologic Epstein-Barr Virus Profile.

Authors:  Timothy Beer; Patrick Dorion
Journal:  Hematol Rep       Date:  2015-06-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.